Css LLC Cure Vac N.V. Put Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	SELL	$49.26 - $74.5 $2.46 Million - $3.73 Million	-50,000 Reduced 83.33%	10,000 $546,000
Q2 2021 Aug 16, 2021	BUY	$56.91 - $127.53 $2.94 Million - $6.59 Million	51,700 Added 622.89%	60,000 $4.41 Million
Q1 2021 May 17, 2021	BUY	$79.79 - $126.29 $343,097 - $543,047	4,300 Added 107.5%	8,300 $759,000
Q4 2020 Feb 16, 2021	BUY	$46.76 - $136.27 $187,040 - $545,080	4,000 New	4,000 $324,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.